204 related articles for article (PubMed ID: 22938460)
1. DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis.
Chen DQ; Yao DX; Zhao HY; Yang SJ
Asian Pac J Cancer Prev; 2012; 13(6):2791-4. PubMed ID: 22938460
[TBL] [Abstract][Full Text] [Related]
2. Predictive role of ERCC1 and XPD genetic polymorphisms in survival of Chinese non-small cell lung cancer patients receiving chemotherapy.
Zhang ZY; Tian X; Wu R; Liang Y; Jin XY
Asian Pac J Cancer Prev; 2012; 13(6):2583-6. PubMed ID: 22938424
[TBL] [Abstract][Full Text] [Related]
3. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
[TBL] [Abstract][Full Text] [Related]
5. Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk.
Hui L; Yue S; Gao G; Chang H; Li X
Tumour Biol; 2014 Aug; 35(8):7451-7. PubMed ID: 24782032
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung.
Lee MS; Liu CY; Su L; Christiani DC
Lung Cancer; 2015 Jul; 89(1):8-12. PubMed ID: 26001533
[TBL] [Abstract][Full Text] [Related]
7. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
[TBL] [Abstract][Full Text] [Related]
8. Implication of polymorphisms in DNA repair genes in prognosis of hepatocellular carcinoma.
Yue AM; Xie ZB; Guo SP; Wei QD; Yang XW
Asian Pac J Cancer Prev; 2013; 14(1):355-8. PubMed ID: 23534753
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
10. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
Zhou CX; Zhao JH
Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
[TBL] [Abstract][Full Text] [Related]
11. Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma.
Wu JS; Chen YP; Wang LC; Yang YJ; Deng CW; Hou BX; He ZL; Chen JX
Genet Mol Res; 2014 May; 13(2):3812-8. PubMed ID: 24938468
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic polymorphisms in ERCC1 and ERCC2/XPD with risk of chronic benzene poisoning in a Chinese occupational population.
Xiao S; Gao L; Liu Y; Yu T; Jin C; Pan L; Zhu G; Lu X
Mutat Res; 2013 Feb; 751(1):52-8. PubMed ID: 23147699
[TBL] [Abstract][Full Text] [Related]
13. Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.
Tibaldi C; Giovannetti E; Vasile E; Mey V; Laan AC; Nannizzi S; Di Marsico R; Antonuzzo A; Orlandini C; Ricciardi S; Del Tacca M; Peters GJ; Falcone A; Danesi R
Clin Cancer Res; 2008 Mar; 14(6):1797-803. PubMed ID: 18347182
[TBL] [Abstract][Full Text] [Related]
14. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis.
Zhao H; Wang LE; Li D; Chamberlain RM; Sturgis EM; Wei Q
Carcinogenesis; 2008 Aug; 29(8):1560-6. PubMed ID: 18635523
[TBL] [Abstract][Full Text] [Related]
15. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.
Ryu JS; Hong YC; Han HS; Lee JE; Kim S; Park YM; Kim YC; Hwang TS
Lung Cancer; 2004 Jun; 44(3):311-6. PubMed ID: 15140544
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes.
Bradbury PA; Kulke MH; Heist RS; Zhou W; Ma C; Xu W; Marshall AL; Zhai R; Hooshmand SM; Asomaning K; Su L; Shepherd FA; Lynch TJ; Wain JC; Christiani DC; Liu G
Pharmacogenet Genomics; 2009 Aug; 19(8):613-25. PubMed ID: 19620936
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk.
Tse D; Zhai R; Zhou W; Heist RS; Asomaning K; Su L; Lynch TJ; Wain JC; Christiani DC; Liu G
Cancer Causes Control; 2008 Dec; 19(10):1077-83. PubMed ID: 18478337
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of DNA repair genes: ERCC1 G19007A and ERCC2/XPD C22541A in a northeastern Chinese population.
Yin J; Li J; Vogel U; Wang H
Biochem Genet; 2005 Oct; 43(9-10):543-8. PubMed ID: 16341770
[TBL] [Abstract][Full Text] [Related]
19. ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis.
Lu X; Xiao S; Jin C; van der Straaten T; Li X
J Clin Lab Anal; 2012 Jan; 26(1):10-5. PubMed ID: 24833529
[TBL] [Abstract][Full Text] [Related]
20. Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis.
Xu Z; Ma W; Gao L; Xing B
Tumour Biol; 2014 Apr; 35(4):3211-21. PubMed ID: 24254311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
